News

A new study by MIT researchers finds that the growing practice of compiling massive, anonymized datasets about people’s movement patterns is a double-edged sword: While it can provide deep insights into human behavior for research, it could also put people’s private data at risk.

Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.

Russian astronauts onboard a spacecraft have reportedly bioprinted a mouse thyroid. This is definitely a world-first in outer space bioprinting.

It's easy to take a lot for granted. Scientists do this when they study stress, the force per unit area on an object. Scientists handle stress mathematically by assuming it to have symmetry, but new supercomputer simulations show that at the atomic level, material stress doesn't behave symmetrically. The findings could help scientists design new materials such as glass or metal that doesn't ice up.

In late 2017 DeepMind introduced AlphaZero, a single system that taught itself from scratch how to master the games of chess, shogi (Japanese chess), and Go, beating a world-champion program in each case. Today, they announce the evalutation of AlphaZero, published in the journal Science, that confirms and updates those preliminary results.

Anti-opioid immunopharmacotherapies (e.g., conjugate vaccines) that sequester drug peripherally, preventing opioids from reaching targeted receptors in the brain, have recently emerged as promising therapeutics.

A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.

The immunogenicity and efficacy of tumor specific antigen vaccination for select antigens has been validated in mouse models of cancer. The researchers believe that clinical trials for human cancer vaccines could start within the next 2-3 years.

Demonstrating the effectiveness of the vaccine candidate in monkeys (non-human primates) is an important milestone because it typically predicts the vaccine will work in humans, enabling further clinical development.

A powerful new biochemical platform is fueling the study of a family of enzymes that are promising targets for cancer treatment.